Skip to content
MedsAcross

Medicine

Topiramate 50 mg capsule

Topiramate · Oral
Available on requestPrescription onlyUS FDAGeneric name

Topiramate 50 mg capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20 • C to 25 • C (68 • F to 77 • F). Protect from moisture.

Key facts

Active ingredient (INN)
Topiramate
Brand
Sold under the generic name
Strength
50 mg
Dosage form
Capsule
Route
Oral
Packs
60 capsules, 500 capsules, 120 capsules and 4 more
Manufacturers
Zydus LifesciencesIndiaAdvagen Pharma
Origin register
US FDA, United States
Storage
Store at 20 • C to 25 • C (68 • F to 77 • F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AX11 Topiramate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 October 2024
Identifiers
RxCUI 205315, 205316, 252413DailyMed set ID e4886adf-199d-4b19-a4ef-75f8f94cb54e, 48169bbc-4fb2-4bc4-9bdd-de71bf7722df, 6f9d59e3-d10d-48f3-af01-83ba3e1e3a2bNDC 68382-498, 72888-230, 65841-846Application ANDA078877, ANDA216683

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
60 capsule, coated pellets in 1 bottle65841-846-14Zydus LifesciencesIndia24 October 2024
60 capsule, coated pellets in 1 bottle68382-498-14Zydus LifesciencesIndia24 October 2024
500 capsule in 1 bottle72888-230-05Advagen Pharma27 May 2025
120 capsule in 1 bottle72888-230-12Advagen Pharma27 May 2025
30 capsule in 1 bottle72888-230-30Advagen Pharma27 May 2025
60 capsule in 1 bottle72888-230-60Advagen Pharma27 May 2025
240 capsule in 1 bottle72888-230-67Advagen Pharma27 May 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 December 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Topiramate

Clinical summary

Topiramate is a prescription medicine indicated for epilepsy, among other approved uses. It is available as tablets, extended-release capsules and capsules for oral use. MedsAcross supplies Topiramate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Topiramate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Topiramate 50 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.